Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re-emerging phenotype is associated with graft function.

Autor: Sabbah S; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Liew A; Newcastle University Translational and Clinical Research Institute, Newcastle, UK., Brooks AM; Newcastle University Translational and Clinical Research Institute, Newcastle, UK., Kundu R; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Reading JL; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Flatt A; Newcastle University Translational and Clinical Research Institute, Newcastle, UK., Counter C; Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, UK., Choudhary P; Diabetes Research Group, Guy's, King's and St. Thomas' School of Medicine, King's College London, London, UK., Forbes S; Edinburgh Transplant Centre and Endocrinology Unit, University of Edinburgh, Edinburgh, UK., Rosenthal MJ; Diabetes Service, Royal Free London NHS Foundation Trust, London, UK., Rutter MK; Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester, UK.; Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Cairns S; Clinical Immunology Department, Scottish National Blood Transfusion Service, Royal Infirmary of Edinburgh, Edinburgh, UK., Johnson P; Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK., Casey J; Edinburgh Transplant Centre and Endocrinology Unit, University of Edinburgh, Edinburgh, UK., Peakman M; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Shaw JA; Newcastle University Translational and Clinical Research Institute, Newcastle, UK.; Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Tree TIM; Department of Immunobiology, Faculty of Life Sciences & Medicine, King's College London, London, UK.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Mar; Vol. 21 (3), pp. 1027-1038. Date of Electronic Publication: 2020 Sep 19.

Protective effect of Cyclo(His-Pro) on peritoneal fibrosis through regulation of HDAC3 expression.

Autor: Kim JE; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea., Han D; Proteomics Core Facility, Seoul National University Hospital, Seoul, Korea., Kim KH; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea., Seo A; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea., Moon JJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Jeong JS; Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Korea., Kim JH; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea., Kang E; Transplantation Center, Seoul National University Hospital, Seoul, Korea., Bae E; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea., Kim YC; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea., Lee JW; Nephrology Clinic, National Cancer Center, Goyang, Korea., Cha RH; Department of Internal Medicine, National Medical Center, Seoul, Korea., Kim DK; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea., Oh KH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Kim YS; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.; Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea., Jung HY; R&D Center, NovMetaPharma Co., Ltd, Pohang, Korea.; School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang, Korea., Yang SH; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.; Kidney Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Jul; Vol. 38 (13), pp. e23819.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients.

Autor: Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB, Mizwicki, Mathew T, Liu, Guanghao, Fiala, Milan, Magpantay, Larry, Sayre, James, Siani, Avi, Mahanian, Michelle

Publikováno v: Journal of Alzheimer's Disease; 2013, Vol. 33 Issue 1, p155-170, 16p